š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
This study evaluates the immunogenicity and safety of Infanrix hexaā¢ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
This study will assess the safety, reactogenicity and immunogenicity of dif...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-24
Trial ID
NCT00985751
Treatments Being Tested
This study is a randomized and controlled phase ā £ clinical trial of the COV...
Status
Completed
Location
Yangchun Center for Disease Control and Prevention
Start Date
2021-11-05
Trial ID
NCT04993365
Treatments Being Tested
This study is a single center , randomized ,controlled and open-label phase...
Status
Completed
Location
Beijing Centers for Diseases Control and Prevention
Start Date
2021-10-15
Trial ID
NCT05499351
This study is an open-label combined randomized double-blind, positive cont...
Status
Completed
Location
Henan Center for Diseases Control and Prevention
Start Date
2023-01-03
Trial ID
NCT05092386
This study will assess the safety, reactogenicity and immunogenicity of two...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-27
Trial ID
NCT01204658
This study is a randomized and controlled Phase IV clinical trial of the CO...
Status
Completed
Location
Yangchun City Center for Disease Control and Prevention
Start Date
2021-11-05
Trial ID
NCT05107557
Treatments Being Tested
This phase 1/2 study will evaluate the safety, reactogenicity and immunogen...
Status
Active Not Recruiting
Location
Fusion Clinical Research
Start Date
2025-06-18
Trial ID
NCT06984094
Treatments Being Tested
The purpose of this follow-up study is to evaluate the persistence of antib...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-31
Trial ID
NCT01738477
Treatments Being Tested